Mitochondria in cancer: in the aspects of tumorigenesis and targeted therapy

Narayanasamy Badrinath1,2, So Young Yoo2,3

  • 1Biomedical Sciences, School of Medicine, Pusan National University, Yangsan, Republic of Korea.

Carcinogenesis
|October 26, 2018
PubMed

Insights

Mitochondria are crucial in cancer, with mutations affecting their function and reactive oxygen species (ROS) production. Targeting mitochondria offers promising cancer therapies by inducing apoptosis, enhancing cancer cell death.

Area of Science:

  • Cell Biology
  • Cancer Biology
  • Biochemistry

Background:

  • Mitochondria are vital organelles in eukaryotic cells, involved in energy production and apoptosis regulation.
  • Mitochondria generate reactive oxygen species (ROS) during cellular respiration, and their dysfunction is linked to cancer development.
  • Mutations in mitochondrial DNA (mtDNA) and nuclear DNA are implicated in various cancers, highlighting mitochondria's dual role.

Purpose of the Study:

  • To review the multifaceted roles of mitochondria in cancer, including their involvement in mutations and apoptosis.
  • To discuss current and emerging mitochondria-targeting strategies for cancer therapy.

Main Methods:

  • Literature review of scientific articles on mitochondria, cancer, mutations, and apoptosis.
  • Analysis of the dual role of mitochondria in tumor development and progression.
  • Examination of therapeutic strategies aimed at mitochondria for cancer treatment.

Main Results:

  • Mitochondrial mutations and ROS production contribute to tumorigenesis.
  • Dysregulation of mitochondria-mediated apoptosis accelerates cancer growth.
  • Mitochondria-targeting therapies show potential in enhancing cancer cell killing.

Conclusions:

  • Mitochondria are key players in cancer, influencing both tumor initiation and progression.
  • Targeting mitochondrial pathways, particularly apoptosis, represents a promising therapeutic avenue for cancer treatment.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
19.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K